Elevate your local knowledge
Sign up for the iNFOnews newsletter today!

NEW BRUNSWICK, N.J. – Johnson & Johnson says its second-quarter profit more than doubled on higher sales of medicines and medical devices
The maker of Tylenol, prescription drugs and medical devices handily beat Wall Street expectation.
New Brunswick, N.J.-based J&J says net income was $3.83 billion, or $1.33 per share, up from $1.41 billion, or 50 cents per share. Last year’s quarter was weighed down by big charges.
Excluding one-time items, net income was $4.29 billion, or $1.48 per share.
Revenue was $17.88 billion, up 8.5 per cent from $16.48 billion a year earlier.
Analysts polled by FactSet were expecting earnings per share of $1.39 and sales of $17.72 billion.
The company raised its profit forecast to $5.40 to $5.47 per share, excluding items. In January, J&J predicted earnings of $5.35 to $5.45 per share.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.